HSTM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HealthStream Inc (HSTM) is not a strong buy for a beginner investor with a long-term focus at this time. The stock shows weak financial performance, insider selling, and a lack of strong positive catalysts. While the technical indicators are neutral, the absence of significant upward momentum and the negative sentiment from analysts and trading trends suggest holding off on an investment.
The MACD is positive but contracting, RSI is neutral at 65.677, and moving averages are converging. The stock is trading near its pivot level of 21.636, with resistance at 22.948 and support at 20.323. There is no clear bullish signal from the technical indicators.
The company addressed AI concerns effectively in its latest earnings call, positioning itself favorably compared to other SaaS names. Revenue increased by 7.37% YoY in Q4 2025.
Net income dropped by 48.17% YoY, EPS decreased by 43.75% YoY, and gross margin declined by 4.07% YoY. Insider selling increased by 146.37% over the last month. Analysts have lowered price targets twice recently, citing an uncertain healthcare environment. No recent news or congress trading data to indicate positive sentiment.
In Q4 2025, revenue grew by 7.37% YoY to $79.71M. However, net income dropped by 48.17% YoY to $2.53M, and EPS fell by 43.75% to $0.09. Gross margin declined to 49.96%, down 4.07% YoY.
Analysts have downgraded the price target twice recently, from $28 to $25 and then to $21, maintaining a Hold rating. Concerns about AI disintermediation in the SaaS sector and an uncertain healthcare environment have been highlighted.
